Vestagen Technical Textiles, Inc., an Orlando, Florida-based medical technology company developing and marketing high performance apparel for healthcare and other demanding applications, completed a $7.0m financing.
Backers in the round, which was a planned extension of its previous financing, included Advent Life Sciences, HealthQuest Capital and others.
The company intends to use the funds to commercialize VESTEX®.
Led by newly named Bill Bold, Chief Executive Officer, who replaced Dale Pfost, PhD, Vestagen develops and markets performance apparel products and technologies. Its VESTEX® active barrier protective technology combines fluid repellent, antimicrobial and breathability properties for everyday protection from fluid exposure and pathogen transmission. It is suitable for a variety of applications, including healthcare, public safety and athletics and is available for use in garment production by approved licensees.